LFVN
What one share of Lifevantage holds
Pharmaceutical Preparations
LifeVantage Corporation (the “Company,” “LifeVantage,” “we,” “us,” or “our”) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. LifeVantage is dedicated to helping people achieve their health, wellness and financial goals.
Lifevantage’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $14.37 |
|---|---|
| Profit | $0.40 |
| Capex (buildings and equipment) | $0.28 |
| Free cash flow | $0.53 |
| Dividends | $0.18 |
| Cash and investments | $1.19 |
| Book value | $2.68 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $14.13 | $0.11 | $0.07 | $0.39 | — | $1.02 |
| 2018 | $14.37 | $0.41 | $0.33 | $0.61 | — | $1.56 |
| 2019 | $15.08 | $0.50 | $0.17 | $1.02 | — | $1.93 |
| 2020 | $15.95 | $0.79 | $0.18 | $1.07 | — | $2.32 |
| 2021 | $15.43 | $0.90 | $0.26 | $0.88 | — | $2.70 |
| 2022 | $15.79 | $0.24 | $0.12 | $0.49 | $0.03 | $2.52 |
| 2023 | $16.98 | $0.20 | $0.24 | $0.30 | $0.12 | $2.75 |
| 2024 | $15.41 | $0.23 | $0.17 | $0.77 | $0.55 | $2.08 |
| 2025 | $17.60 | $0.76 | $0.11 | $0.81 | $0.17 | $2.79 |
| 2026 | $14.37 | $0.40 | $0.28 | $0.53 | $0.18 | $2.68 |